2,258
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Anti-obesity effect of extract from fermented Curcuma longa L. through regulation of adipogenesis and lipolysis pathway in high-fat diet-induced obese rats

, , , , , , , , & show all
Article: 30428 | Received 16 Nov 2015, Accepted 19 Dec 2015, Published online: 27 Jan 2016

References

  • Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999; 282: 1523–9.
  • Rose DP, Gracheck PJ, Vona-Davis L. The interactions of obesity, inflammation and insulin resistance in breast cancer. Cancers (Basel). 2015; 7: 2147–68.
  • Frühbeck G, Gómez-Ambrosi J, Muruzábal FJ, Burrell MA. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol Endocrinol Metab. 2001; 280: E827–E47.
  • Ntambi JM, Young-Cheul K. Adipocyte differentiation and gene expression. J Nutr. 2000; 130: 3122S–6S. [PubMed Abstract].
  • Darlington GJ, Ross SE, MacDougald OA. The role of C/EBP genes in adipocyte differentiation. J Biol Chem. 1998; 273: 30057–60.
  • Morrison RF, Farmer SR. Hormonal signaling and transcriptional control of adipocyte differentiation. J Nutr. 2000; 130: 3116S–21S. [PubMed Abstract].
  • Hietanen E, Greenwood MR. A comparison of lipoprotein lipase activity and adipocyte differentiation in growing male rats. J Lipid Res. 1977; 18: 480–90. [PubMed Abstract].
  • Duncan RE, Ahmadian M, Jaworski K, Sarkadi-Nagy E, Sul HS. Regulation of lipolysis in adipocytes. Annu Rev Nutr. 2007; 27: 79–101.
  • Gaidhu MP, Anthony NM, Patel P, Hawke TJ, Ceddia RB. Dysregulation of lipolysis and lipid metabolism in visceral and subcutaneous adipocytes by high-fat diet: role of ATGL, HSL, and AMPK. Am J Physiol Cell Physiol. 2010; 298: C961–71.
  • Ceddia RB. The role of AMP-activated protein kinase in regulating white adipose tissue metabolism. Mol Cell Endocrinol. 2013; 366: 194–203.
  • Kohjima M, Higuchi N, Kato M, Kotoh K, Yoshimoto T, Fujino T, etal. SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease. Int J Mol Med. 2008; 21: 507–11. [PubMed Abstract].
  • Yun JW. Possible anti-obesity therapeutics from nature – a review. Phytochemistry. 2010; 71: 1625–41.
  • Witkin JM, Li X. Curcumin, an active constiuent of the ancient medicinal herb Curcuma longa L.: some uses and the establishment and biological basis of medical efficacy. CNS Neurol Disord Drug Targets. 2013; 12: 487–97.
  • Araújo CC, Leon LL. Biological activities of Curcuma longa L. Mem Inst Oswaldo Cruz. 2001; 96: 723–8.
  • Kim Y, You Y, Yoon HG, Lee YH, Kim K, Lee J, etal. Hepatoprotective effects of fermented Curcuma longa L. on carbon tetrachloride-induced oxidative stress in rats. Food Chem. 2014; 151: 148–53.
  • Chuah LO, Yeap SK, Ho WY, Beh BK, Alitheen NB. In vitro and in vivo toxicity of garcinia or hydroxycitric Acid: a review. Evid Based Complement Alternat Med. 2012; 2012: 197920.
  • Bray GA, Popkin BM. Dietary fat intake does affect obesity!. Am J Clin Nutr. 1998; 68: 1157–73. [PubMed Abstract].
  • Varga O, Harangi M, Olsson IA, Hansen AK. Contribution of animal models to the understanding of the metabolic syndrome: a systematic overview. Obes Rev. 2010; 11: 792–807.
  • Ghibaudi L, Cook J, Farley C, van Heek M, Hwa JJ. Fat intake affects adiposity, comorbidity factors, and energy metabolism of Sprague-Dawley rats. Obes Res. 2002; 10: 956–63.
  • Yatera Y, Shibata K, Furuno Y, Sabanai K, Morisada N, Nakata S, etal. Severe dyslipidaemia, atherosclerosis, and sudden cardiac death in mice lacking all NO synthases fed a high-fat diet. Cardiovasc Res. 2010; 87: 675–82.
  • Rosen ED, Spiegelman BM. Adipocytes as regulators of energy balance and glucose homeostasis. Nature. 2006; 444: 847–53.
  • Rutkowski JM, Stern JH, Scherer P. The cell biology of fat expansion. J Cell Biol. 2015; 208: 501–12.
  • Kadowaki T, Hara K, Kubota N, Tobe K, Terauchi Y, Yamauchi T, etal. The role of PPARgamma in high-fat diet-induced obesity and insulin resistance. J Diabetes Complications. 2002; 16: 41–5.
  • Rosen ED, Hsu CH, Wang X, Sakai S, Freeman MW, Gonzalez FJ, etal. C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev. 2002; 16: 22–6.
  • Schadinger SE, Bucher NL, Schreiber BM, Farmer SR. PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes. Am J Physiol Endocrinol Metab. 2005; 288: E1195–205.
  • Farmer SR. Transcriptional control of adipocyte formation. Cell Metab. 2006; 4: 263–73.
  • Ejaz A, Wu D, Kwan P, Meydani M. Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice. J Nutr. 2009; 139: 919–25.
  • Zhao J, Sun XB, Ye F, Tian WX. Suppression of fatty acid synthase, differentiation and lipid accumulation in adipocytes by curcumin. Mol Cell Biochem. 2011; 351: 19–28.
  • Redinger RN. Fat storage and the biology of energy expenditure. Transl Res. 2009; 154: 52–60.
  • Abu-Elheiga L, Matzuk MM, Abo-Hashema KA, Wakil SJ. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science. 2001; 291: 2613–16.
  • Herms A, Bosch M, Reddy BJ, Schieber NL, Fajardo A, Rupérez C, etal. AMPK activation promotes lipid droplet dispersion on detyrosinated microtubules to increase mitochondrial fatty acid oxidation. Nat Commun. 2015; 6: 7176.
  • Yoon MJ, Lee GY, Chung JJ, Ahn YH, Hong SH, Kim JB. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha. Diabetes. 2006; 55: 2562–70.
  • Lago F, Gómez R, Gómez-Reino JJ, Dieguez C, Gualillo O. Adipokines as novel modulators of lipid metabolism. Trends Biochem Sci. 2009; 34: 500–10.
  • Yu JG, Javorschi S, Hevener AL, Kruszynska YT, Norman RA, Sinha M, etal. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes. 2002; 51: 2968–74.